Nav: Home

Mobile gold fingers

March 27, 2017

Drugs containing gold have been used for centuries to treat conditions like rheumatoid arthritis. In addition, they might be effective against cancer and HIV. One mechanism by which they work could occur because gold ions force the zinc ions out of zinc fingers--looped, nucleic acid binding protein domains. American researchers have characterized such "gold fingers" using ion mobility mass spectrometry. As reported in the journal Angewandte Chemie, they identified the exact gold binding sites.

"The zinc ions in zinc fingers bind to four sulfur or nitrogen atoms of the protein's cysteine and histidine residues," explains Nicholas P. Farrell of Virginia Commonwealth University (Richmond, USA). "Gold ions bind to just two amino acid fragments and change the conformation of the protein. The "gold fingers" are no longer able to bind to nucleic acids, which may be therapeutically useful."

Although there are a variety of potential binding sites for metal ions, each metalloprotein usually prefers a single conformation. It was previously not possible to determine where the specific binding sites were in a mixture of conformers. Farrell and his team have now closely examined two gold fingers. According to Farrell, "replacing the zinc in zinc finger 3 of Sp1 transcription factor leads to only a single gold finger species." The researchers identified this as having a linear Cys-Au-His bond. In the case of the HIV nucleocapsid protein, which plays a critical role in the replication of the virus, "putting gold in the zinc finger 2 of the protein (NCp7-F2), leads to three different gold finger species with linear Cys-Au-Cys motifs, one of which is clearly predominant."

The researchers' success stems from their use of a special analytical method called travelling-wave ion mobility mass spectrometry (TWIM-MS). In this technique, the molecules to be analyzed are ionized and the ions accelerated by an electric field in a gas. Collisions with the gas molecules cause the ions to be slowed. Large, voluminous molecules are slowed more than small, compact ones because they collide more frequently. This makes it possible to differentiate and separate isomers as well, because although they have the same mass, their different geometries result in different mobility. Once separated according to their mobility, the individual ions can now be fragmented through collision induced dissociation (CID) and the fragments measured again by mass spectrometry. This makes it possible to characterize shorter peptides that remain bound to gold.

"In this way, we were able to identify the specific binding sites and modes for the gold-modified zinc fingers NCp7-F2 and Sp1-F3," says Farrell. "Ion mobility mass spectrometry thus provides important information about the changes in geometry caused by the exchange of zinc in the zinc finger proteins, as well as the selectivity and reactivity of such reactions. This could be of benefit in the search for new metal-based antiviral and antitumor drugs."
-end-
About the Author

Dr. Farrell is Professor of Chemistry at Virginia Commonwealth University and a member of The Massey Cancer Center. His specialty is in the applications of inorganic chemistry in medicine. The research was funded by the National Science Foundation and performed by visiting international scholars from Brazil and China.

mailto:npfarrell@vcu.edu

Wiley

Related Hiv Articles:

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.
Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
First ever living donor HIV-to-HIV kidney transplant
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV.
The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.
HIV RNA expression inhibitors may restore immune function in HIV-infected individuals
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity.
HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world.
State-of-the-art HIV drug could curb HIV transmission, improve survival in India
An HIV treatment regimen already widely used in North America and Europe would likely increase the life expectancy of people living with HIV in India by nearly three years and reduce the number of new HIV infections by 23 percent with minimal impact on the country's HIV/AIDS budget.
More Hiv News and Hiv Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#540 Specialize? Or Generalize?
Ever been called a "jack of all trades, master of none"? The world loves to elevate specialists, people who drill deep into a single topic. Those people are great. But there's a place for generalists too, argues David Epstein. Jacks of all trades are often more successful than specialists. And he's got science to back it up. We talk with Epstein about his latest book, "Range: Why Generalists Triumph in a Specialized World".
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.